A detailed history of Keybank National Association transactions in Organon & Co. stock. As of the latest transaction made, Keybank National Association holds 10,217 shares of OGN stock, worth $148,963. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,217
Previous 22,964 55.51%
Holding current value
$148,963
Previous $475,000 58.95%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$18.65 - $23.03 $237,731 - $293,563
-12,747 Reduced 55.51%
10,217 $195,000
Q2 2024

Jul 31, 2024

SELL
$17.45 - $21.96 $14,117 - $17,765
-809 Reduced 3.4%
22,964 $475,000
Q1 2024

May 14, 2024

SELL
$13.78 - $18.8 $7,634 - $10,415
-554 Reduced 2.28%
23,773 $446,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $33,660 - $53,241
-3,074 Reduced 11.22%
24,327 $350,000
Q3 2023

Nov 08, 2023

SELL
$16.59 - $23.77 $13,255 - $18,992
-799 Reduced 2.83%
27,401 $475,000
Q2 2023

Aug 01, 2023

SELL
$19.27 - $24.63 $82,571 - $105,539
-4,285 Reduced 13.19%
28,200 $586,000
Q1 2023

May 10, 2023

SELL
$21.42 - $32.08 $249,478 - $373,635
-11,647 Reduced 26.39%
32,485 $764,000
Q4 2022

Jan 31, 2023

BUY
$23.31 - $28.61 $186,946 - $229,452
8,020 Added 22.21%
44,132 $1.23 Million
Q3 2022

Oct 27, 2022

SELL
$23.4 - $34.25 $101,953 - $149,227
-4,357 Reduced 10.77%
36,112 $845,000
Q2 2022

Aug 08, 2022

SELL
$31.66 - $38.9 $259,896 - $319,330
-8,209 Reduced 16.86%
40,469 $1.37 Million
Q1 2022

Apr 28, 2022

SELL
$30.45 - $39.36 $532,631 - $688,485
-17,492 Reduced 26.43%
48,678 $1.7 Million
Q4 2021

Feb 07, 2022

SELL
$28.67 - $37.13 $842,410 - $1.09 Million
-29,383 Reduced 30.75%
66,170 $2.02 Million
Q3 2021

Nov 08, 2021

SELL
$28.63 - $35.64 $1.22 Million - $1.52 Million
-42,547 Reduced 30.81%
95,553 $3.13 Million
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $3.93 Million - $5.25 Million
138,100 New
138,100 $4.18 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.